Ajay Goel1, Clement Richard Boland. 1. Department of Internal Medicine, Division of Gastroenterology, Baylor Sammons Cancer Center, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas 75246, USA.
Abstract
PURPOSE OF REVIEW: Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths in the Western world, but our understanding of this disease is incomplete. The recent advent of new technologies has provided novel insights into the pathogenesis of CRC. RECENT FINDINGS: Genome-wide association studies have recently linked CRC to 10 common genetic variants or single-nucleotide polymorphisms that map to chromosomes 8q23, 8q24, 10p14, 11q23, 14q22, 15q13, 16q22, 18q21, 19q13 and 20p1. However, the causal significance of these variants is not understood, and some are located in poorly characterized genomic regions or gene deserts. Recent studies indicate that the single-nucleotide polymorphism rs6983267, which maps to 8q24, serves as an enhancer of MYC expression by binding T cell factor 4 (TCF4) and influencing Wnt signaling. In addition, several microRNAs interact with genes such as K-RAS, APC, p53, PTEN, TCF4, COX-2, DNMT3a and DNMT3b. Germline hypermethylation of the DNA mismatch repair genes MLH1 and MSH2 may serve as predisposing events in some CRC patients. SUMMARY: Recent studies have elucidated novel mechanisms involved in CRC, including the involvement of single-nucleotide polymorphisms not located within traditional genes, the role of microRNAs and epimutations in DNA mismatch repair genes. Interestingly, most of this progress has been made by understanding DNA that does not encode genes.
PURPOSE OF REVIEW: Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths in the Western world, but our understanding of this disease is incomplete. The recent advent of new technologies has provided novel insights into the pathogenesis of CRC. RECENT FINDINGS: Genome-wide association studies have recently linked CRC to 10 common genetic variants or single-nucleotide polymorphisms that map to chromosomes 8q23, 8q24, 10p14, 11q23, 14q22, 15q13, 16q22, 18q21, 19q13 and 20p1. However, the causal significance of these variants is not understood, and some are located in poorly characterized genomic regions or gene deserts. Recent studies indicate that the single-nucleotide polymorphism rs6983267, which maps to 8q24, serves as an enhancer of MYC expression by binding T cell factor 4 (TCF4) and influencing Wnt signaling. In addition, several microRNAs interact with genes such as K-RAS, APC, p53, PTEN, TCF4, COX-2, DNMT3a and DNMT3b. Germline hypermethylation of the DNA mismatch repair genes MLH1 and MSH2 may serve as predisposing events in some CRC patients. SUMMARY: Recent studies have elucidated novel mechanisms involved in CRC, including the involvement of single-nucleotide polymorphisms not located within traditional genes, the role of microRNAs and epimutations in DNA mismatch repair genes. Interestingly, most of this progress has been made by understanding DNA that does not encode genes.
Authors: Tsun Leung Chan; Siu Tsan Yuen; Chi Kwan Kong; Yee Wai Chan; Annie S Y Chan; Wai Fu Ng; Wai Yin Tsui; Michelle W S Lo; Wing Yip Tam; Vivian S W Li; Suet Yi Leung Journal: Nat Genet Date: 2006-09-03 Impact factor: 38.330
Authors: Alan M Pittman; Emily Webb; Luis Carvajal-Carmona; Kimberley Howarth; Maria Chiara Di Bernardo; Peter Broderick; Sarah Spain; Axel Walther; Amy Price; Kate Sullivan; Philip Twiss; Sarah Fielding; Andrew Rowan; Emma Jaeger; Jayaram Vijayakrishnan; Ian Chandler; Steven Penegar; Mobshra Qureshi; Steven Lubbe; Enric Domingo; Zoe Kemp; Ella Barclay; Wendy Wood; Lynn Martin; Maggie Gorman; Huw Thomas; Julian Peto; Timothy Bishop; Richard Gray; Eamonn R Maher; Anneke Lucassen; David Kerr; Gareth R Evans; Tom van Wezel; Hans Morreau; Juul T Wijnen; John L Hopper; Melissa C Southey; Graham G Giles; Gianluca Severi; Sergi Castellví-Bel; Clara Ruiz-Ponte; Angel Carracedo; Antoni Castells; Asta Försti; Kari Hemminki; Pavel Vodicka; Alessio Naccarati; Lara Lipton; Judy W C Ho; K K Cheng; Pak C Sham; J Luk; Jose A G Agúndez; Jose M Ladero; Miguel de la Hoya; Trinidad Caldés; Iina Niittymäki; Sari Tuupanen; Auli Karhu; Lauri A Aaltonen; Jean-Baptiste Cazier; Ian P M Tomlinson; Richard S Houlston Journal: Hum Mol Genet Date: 2008-08-27 Impact factor: 6.150
Authors: Megan P Hitchins; Justin J L Wong; Graeme Suthers; Catherine M Suter; David I K Martin; Nicholas J Hawkins; Robyn L Ward Journal: N Engl J Med Date: 2007-02-15 Impact factor: 91.245
Authors: Clemens Schafmayer; Stephan Buch; Henry Völzke; Witigo von Schönfels; Jan Hendrik Egberts; Bodo Schniewind; Mario Brosch; Andreas Ruether; Andre Franke; Micaela Mathiak; Bence Sipos; Tobias Henopp; Jasmin Catalcali; Stephan Hellmig; Abdou ElSharawy; Alexander Katalinic; Markus M Lerch; Ulrich John; Ulrich R Fölsch; Fred Fändrich; Holger Kalthoff; Stefan Schreiber; Michael Krawczak; Jürgen Tepel; Jochen Hampe Journal: Int J Cancer Date: 2009-01-01 Impact factor: 7.396
Authors: Richard S Houlston; Emily Webb; Peter Broderick; Alan M Pittman; Maria Chiara Di Bernardo; Steven Lubbe; Ian Chandler; Jayaram Vijayakrishnan; Kate Sullivan; Steven Penegar; Luis Carvajal-Carmona; Kimberley Howarth; Emma Jaeger; Sarah L Spain; Axel Walther; Ella Barclay; Lynn Martin; Maggie Gorman; Enric Domingo; Ana S Teixeira; David Kerr; Jean-Baptiste Cazier; Iina Niittymäki; Sari Tuupanen; Auli Karhu; Lauri A Aaltonen; Ian P M Tomlinson; Susan M Farrington; Albert Tenesa; James G D Prendergast; Rebecca A Barnetson; Roseanne Cetnarskyj; Mary E Porteous; Paul D P Pharoah; Thibaud Koessler; Jochen Hampe; Stephan Buch; Clemens Schafmayer; Jurgen Tepel; Stefan Schreiber; Henry Völzke; Jenny Chang-Claude; Michael Hoffmeister; Hermann Brenner; Brent W Zanke; Alexandre Montpetit; Thomas J Hudson; Steven Gallinger; Harry Campbell; Malcolm G Dunlop Journal: Nat Genet Date: 2008-11-16 Impact factor: 38.330
Authors: E Bandrés; E Cubedo; X Agirre; R Malumbres; R Zárate; N Ramirez; A Abajo; A Navarro; I Moreno; M Monzó; J García-Foncillas Journal: Mol Cancer Date: 2006-07-19 Impact factor: 27.401
Authors: E Lastra; M García-González; B Llorente; C Bernuy; M J Barrio; L Pérez-Cabornero; M Durán; C García-Girón Journal: Clin Transl Oncol Date: 2012-04 Impact factor: 3.405